Updates
Change in address of Registrar & Share Transfer Agent.09-03-2017
Press Release
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (U.S. FDA) for Rizatriptan Benzoate ODT 5mg & 10mg and Rizatriptan Benzoate Tablets USP, 5mg & 10mg which are therapeutically equivalent to Maxalt MLT Tablets 5mg & 10mg and Maxalt Tablets 5mg 10mg of Merck & Company, Inc.08-03-2017
Clarification sought from Unichem Laboratories Ltd
The Exchange has sought clarification from Unichem Laboratories Ltd on March 06, 2017, with reference to news appeared in CNBC TV18 dated March 06, 2017. "USFDA completes inspection of Ghazibad unit with no observation on 3rd march"The reply is awaited.06-03-2017
Updates
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.06-03-2017
Unichem Laboratories: Good prognosis
Measures to rev up growth in domestic and global markets are paying off12-02-2017
Investor Presentation for December 31, 2016
Unichem Laboratories Ltd has informed BSE about : 1. Investor Presentation for the period ended December 31, 201606-02-2017
Transcript on unaudited financial results for the quarter and nine months ended December 31, 2016
Unichem Laboratories Ltd has submitted to BSE a copy of Transcript on unaudited financial results for the quarter and nine months ended December 31, 2016.31-01-2017
Unichem Labs' Q3 net profit up 26% at Rs 26 cr
Drug firm Unichem Laboratories today reported a 26.33 per cent rise in standalone net profit to Rs 26.10 crore for the quarter ended December 31, mainly on account of robust sales. The company...21-01-2017
Investor Release for December 31, 2016
Unichem Laboratories Ltd has informed BSE about : 1. Investor Release for the period ended December 31, 201621-01-2017
Outcome of Board Meeting
Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 21, 2017, inter alia :- Approved allotment of 2,025 equity shares having a face value of Rs. 2/- each, pursuant to exercise of options under the Employee Stock Option Scheme, 2008.The meeting commenced at 11.30 a.m. and concluded at 1 p.m.21-01-2017